Taiwan FDA registration 5338cfdc6bec60bc3a1f93c4618ffe98
"Leica" Bond Ready-to-Use Primary Antibody CD117 (EP10) (Non-Sterile)
TW: “錸卡” 邦德即用型一級抗體CD117(EP10) (未滅菌)
Taiwan·Risk Class 1·MD·LEICA BIOSYSTEMS NEWCASTLE LTD.·Registered Sep 07, 2018 – Sep 07, 2028ActiveRegistration details
- Analysis ID
- 5338cfdc6bec60bc3a1f93c4618ffe98
- License Form
- Ministry of Health Medical Device Import No. 019583
- Customs Code
- DHA09401958309
Company information
- Manufacturer
- LEICA BIOSYSTEMS NEWCASTLE LTD.
- Manufacturer Country
- United Kingdom
- Authorized Representative
- BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.)
Product details
- Intended Use
- Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B1860 Immunopathological histochemical reagents and kits
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Sep 07, 2018
- Expiry Date
- Sep 07, 2028
About this record
Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody CD117 (EP10) (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 5338cfdc6bec60bc3a1f93c4618ffe98 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices